Crispr Therapeutics shares owned by Spouting Rock Asset Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Spouting Rock Asset Management
from 13F filings
Historical chart of Spouting Rock Asset Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Spouting Rock Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Spouting Rock Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $627k | 10k | 62.60 |
| 2023-09-30 | $454k | 10k | 45.39 |
| 2023-06-30 | $803k | 14k | 56.14 |
| 2023-03-31 | $647k | 14k | 45.23 |
| 2022-12-31 | $581k | 14k | 40.65 |
| 2022-09-30 | $934k | 14k | 65.33 |
| 2022-06-30 | $1.3M | 21k | 60.76 |
| 2022-03-31 | $1.3M | 21k | 62.79 |
More positions owned by Spouting Rock Asset Management
View all positions for Spouting Rock Asset Management